Matches in Nanopublications for { ?s ?p "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP18885.RAAh2F2fRlrK751X_OpKl9GybvNINwwfk5TG8wRdTDc50130_assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18885.RAAh2F2fRlrK751X_OpKl9GybvNINwwfk5TG8wRdTDc50130_provenance.
- NP22476.RAKFQDlW0EY4W1tU1Gdcll9s-DzeJlQbqgdQRUsy4qM5k130_assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22476.RAKFQDlW0EY4W1tU1Gdcll9s-DzeJlQbqgdQRUsy4qM5k130_provenance.
- NP18095.RARDRidfnSEZjPnB6XBNtd43ADihdg8BMYl6WyfStrA9E130_assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18095.RARDRidfnSEZjPnB6XBNtd43ADihdg8BMYl6WyfStrA9E130_provenance.
- NP21945.RAhyMpYyZaOgUZ5Dm5IWuy3bTuOFSnmej79e8GqF1eC1c130_assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21945.RAhyMpYyZaOgUZ5Dm5IWuy3bTuOFSnmej79e8GqF1eC1c130_provenance.
- assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP774801.RAEyvQXNmMXp7h8XLt1DTESIkHMWNDgT9fw1bGN1658wA130_assertion description "[IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774801.RAEyvQXNmMXp7h8XLt1DTESIkHMWNDgT9fw1bGN1658wA130_provenance.